Concerned about falling behind eli lilly and co (LLY.US) and novo-nordisk a/s (NVO.US), the indian team urges an early launch of Wegovy in india.
Due to concerns about falling behind its competitor eli lilly and co in the potential huge market of india, the Indian team of the Danish pharmaceutical giant novo-nordisk a/s has been pushing the company to launch its popular weight loss drug Wegovy in india earlier.
Global pharmaceutical leader eli lilly and co and Luye Pharma (02105) cooperate to start a new upswing in the pharmaceutical industry.
Competition in the global market of weight-loss drugs targeting GLP-1 has heated up. Domestic Biotech company LK Healthcare (02105) is expected to be the first to share this large global market for fat loss and muscle gains.
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $994
Technology stocks have become the market leader! Will the Pioneer Growth ETF outperform the s&p 500 again in 2025?
The Vanguard Growth etf has a strong record of outperforming the s&p 500, having surpassed this index on average every year since its establishment in 2004.
Why Is Eli Lilly and Company (LLY) Among Louis Navellier's Top Stock Picks Heading Into 2025?